4
GLOBAL INDUSTRY INSIGHT: Breast Cancer Market Size, Share, Development, Growth and Demand Forecast to 2020

Breast Cancer Market Size, Share, Growth and Demand Forecast to 2020

Embed Size (px)

Citation preview

Page 1: Breast Cancer Market Size, Share, Growth and Demand Forecast to 2020

GLOBAL INDUSTRY INSIGHT: Breast Cancer Market Size, Share, Development, Growth and Demand

Forecast to 2020

Page 2: Breast Cancer Market Size, Share, Growth and Demand Forecast to 2020

Global Breast Cancer Market Size, Share, Development, Growth

and Demand Forecast to 2020

Cancer is a disease characterized by uncontrolled growth of cell. There are about 100 different types of cancer

and each is classified by the type of cell where it occurs and affects. Breast cancer is mostly prevalent in women,

however, breast cancer in men is rare. It is frequently diagnosed in aged women and one of the leading causes of

death among them. Some of the most common types of breast cancer are ductal carcinoma in situ (DCIS), lobular

carcinoma and invasive ductal carcinoma.

DCIS, also known as intraductal carcinoma, begins in the lining of the milk ducts. Milk ducts are thin tubes

carrying milk from lobules of the breast to the nipple. Lobule carcinoma originates in the lobules or milk glands of

the breast. Invasive ductal carcinoma is the most common type of breast cancer. It starts in a milk duct of the

breast, ruptures through the wall of the duct and grows into the fatty tissue of the breast. It spreads to other parts

of body through bloodstream.

For more information visit: https://www.psmarketresearch.com/market-analysis/-breast-cancer-market

The global breast cancer market covers various diagnostic technologies and therapeutic drugs. Diagnostic

segment is further sub-segmented into various tests which are used to diagnose breast cancer. Some of the

major diagnostic tests are biopsy, mammography, MRI, etc. Therapeutic segment covers hormone therapies and

chemotherapy drugs. Some of the major drugs are Trastuzumab, Bevacizumab, Anastrozole, Capecitabine,

Carboplatin, Denosumab, Docetaxel, Doxorubicin, Eribulin, Exemestane, Fluorouracil, Fulvestrant, Gemcitabine,

Ixabepilone, Lapatinib, Letrozole, Methotrexate, Paclitaxel and Tamoxifen.

North America accounts the largest global breast cancer market followed by Europe. The U.S., followed by

Canada, is the largest market for breast cancer in North America. Key driving factor for this market is increasing

prevalence of breast cancer in the region. Germany, France and the U.K. are some of the largest markets for

breast cancer in Europe region. However, Asia-Pacific represents the fastest growing region in the global breast

cancer market. This is due to improving healthcare infrastructure and increasing awareness among people about

breast cancer. In developing countries, such as China and India, government has launched several programs and

initiatives which increase awareness about the disease. It has led to significant rise in demand of breast cancer

diagnostics and therapeutics for disease management. In addition, less stringent wages and availability of skilled

labor attracts manufacturing companies to invest in developing countries.

Request for Table of Content: https://www.psmarketresearch.com/market-analysis/-Breast-Cancer-

Market/toc-sample

© P&S Market Research. All rights reserved 2

Page 3: Breast Cancer Market Size, Share, Growth and Demand Forecast to 2020

Global Breast Cancer Market Size, Share, Development, Growth

and Demand Forecast to 2020

Increasing prevalence of the disease is a key driving factor for the global breast cancer market. Increasing

awareness among people about the disease and rising number of geriatric women around the world are also

supporting the growth of global breast cancer market. In addition, increased research in the field of oncology and

development of biomarker has also fueled the growth of global breast cancer market. Increasing demand of

advanced therapeutic drugs and extensive drug pipeline holds immense potential to the growth of the global

breast cancer market.

However, patent expiry of various blockbuster drugs is key restraint of the global breast cancer market. Stringent

regulations and legislations and side-effects of chemotherapy drugs also hinder the growth of global breast

cancer market. Increasing mergers and acquisitions between drug manufacturing companies and government

bodies are some of the major trends in global breast cancer market.

Browse Other Related Report at: https://www.psmarketresearch.com/industry-report/healthcare

Some of the major competitors in the market are Astrazeneca PLC, F. Hoffmann-La Roche Ltd, Eli Lilly and

Company, Novartis AG, Sanofi-Aventis. Pfizer, Inc., Bristol-Myers Squibb Company, Bayer AG, GlaxoSmithKline

plc and Teva Pharmaceutical Industries Ltd.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for

various geographies around the globe. We provide market research reports, industry forecasting reports,

business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate

forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through

their interaction with leading companies of the concerned domain. We help our clients with B2B market research

and assist them in identifying various windows of opportunity, and framing informed and customized business

expansion strategies in different regions.

Contact:

Abhishek

Executive – Client Partner

347, 5th Ave. #1402

New York City, NY - 10016

© P&S Market Research. All rights reserved 3

Page 4: Breast Cancer Market Size, Share, Growth and Demand Forecast to 2020

Global Breast Cancer Market Size, Share, Development, Growth

and Demand Forecast to 2020

Toll-free: +1-888-778-7886 (USA/Canada)

Email: [email protected]

Web: https://www.psmarketresearch.com

© P&S Market Research. All rights reserved 4